Applied Clinical Trials podcast

ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal

0:00
1:57
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder
In today’s ACT Brief, we examine why community research needs lasting financing and infrastructure, how electronic outcome tools can strengthen neuroscience endpoints, and how Teva is licensing two biosimilars from Samsung Bioepis.

Fler avsnitt från "Applied Clinical Trials"